During the past decade, 1st Department of Internal Medicine, General University Hospital of Ioannina conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "1st Department of Internal Medicine, General University Hospital of Ioannina" #1 sponsor was "Hellenic Institute for the Study of Sepsis" with 5 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "University of Ioannina" with 2 trials sponsored, "Pfizer" with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "1st Department of Internal Medicine, General University Hospital of Ioannina" #1 collaborator was "Sanofi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "1st Department of Internal Medicine, General University Hospital of Ioannina" are "COVID-19" (3 trials), "Corona Virus Infection" (3 trials), "Virus Diseases" (3 trials), "Idiopathic Pulmonary Fibrosis" (2 trials) and "Carcinoma, Basal Cell" (1 trials). Many other conditions were trialed in "1st Department of Internal Medicine, General University Hospital of Ioannina" in a lesser frequency.

Most popular intervention types in "1st Department of Internal Medicine, General University Hospital of Ioannina" are "Drug" (13 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Anakinra" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Alphacalcidol" (1 trials) and "BCG vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "1st Department of Internal Medicine, General University Hospital of Ioannina" are 14 trials for "All" genders.

Currently, there are NaN active trials in "1st Department of Internal Medicine, General University Hospital of Ioannina". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in 1st Department of Internal Medicine, General University Hospital of Ioannina, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in 1st Department of Internal Medicine, General University Hospital of Ioannina, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".